Zoonotic and emerging infectious diseases represent an increasing and very real threat to global health, and it is essential that we expand our understanding of the pathogenesis and prevention of these diseases because of the increasing density of human populations, the increased exposure to domestic animal populations, and the crowding of wildlife into limited areas with frequent livestock and human contact. To address the growing need for infectious disease research, a COBRE Center of Excellence was established at Montana State University (MSU), with the goal of positioning Montana as a national leader in research on zoonotic infectious diseases. Over the past 9 years, the Center has been extremely successful, resulting in infrastructure development (facilities and equipment), recruitment and support of junior investigators (7 COBRE Projects, 6 new hires, and 20 Pilot Projects), and formation of a cohesive Center of investigators. The synergism of these components has resulted in the establishment of a solid foundation for infectious disease research in the region. Importantly, these efforts have fostered faculty career development and have created a pipeline of new researchers with interest and expertise in infectious disease pathogenesis. An essential component of our Center of Excellence is a state-of-the-art Cellular Analysis Core (Core B). This Core provides service, consulting, mentoring, and training in flow cytometry, confocal microscopy, and histology. Previous COBRE l/ll funding, combined with an investment in new equipment of neariy $900,000 specifically for flow cytometry and >$1.6 million in all Core B components combined over the past nine years has allowed us to establish facilities that are unrivaled in the university, state, and region. The Cellular Analysis Core was integral to the success of neariy all COBRE-funded projects, as well as an incredible asset for the university, in general. This Core serves as the cornerstone for the Center now and into the future, beyond COBRE III. The primary objectives in COBRE III will be to continue to expand the capabilities and use of the Cell Analysis Core, and position it for long-term sustainability.
Four specific Aims will be pursued to address these objectives:
Specific Aim 1 : To provide and maintain state-of-the-art instrumentation for use in qualitative and quantitative cell analysis in support of COBRE funded Pilot Grant projects. Center research programs, and other MSU research programs;
Specific Aim 2 : To provide instruction and mentoring per the capabilities of the Cellular Analysis Core;
Specific Aim 3 : To provide service and consulting in flow cytometry, confocal microscopy, and histology;
and Specific Aim 4 : To pursue ongoing assessment of the effectiveness of the Cellular Analysis Core. The Cellular Analysis Core will continue to be highly interactive and collaborative, and will play an important role in expanding the infectious disease research enterprise in Montana.

Public Health Relevance

The Cellular Analysis Core provides the infrastructure and organizational support necessary for effective efficient use of flow cytometry, confocal microscopy, and histology in biomedical research. These analytical approaches are of central importance to research on zoonotic and emerging diseases, and the Cellular Analysis Core will facilitate accomplishment of the goals of COBRE Phase III, thus leading to a sustainable Center of Biomedical Research Excellence.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Montana State University - Bozeman
United States
Zip Code
Plowright, Raina K; Parrish, Colin R; McCallum, Hamish et al. (2017) Pathways to zoonotic spillover. Nat Rev Microbiol 15:502-510
Vergelli, Claudia; Schepetkin, Igor A; Ciciani, Giovanna et al. (2017) Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists. Drug Dev Res 78:49-62
Páez, D J; Giles, J; McCallum, H et al. (2017) Conditions affecting the timing and magnitude of Hendra virus shedding across pteropodid bat populations in Australia. Epidemiol Infect 145:3143-3153
Jackson, Ryan N; van Erp, Paul Bg; Sternberg, Samuel H et al. (2017) Conformational regulation of CRISPR-associated nucleases. Curr Opin Microbiol 37:110-119
Kirpotina, Liliya N; Schepetkin, Igor A; Khlebnikov, Andrei I et al. (2017) 4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists. Biochem Pharmacol 142:120-132
Stama, Madia Letizia; ?lusarczyk, Joanna; Lacivita, Enza et al. (2017) Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation. Eur J Med Chem 141:703-720
Özek, Gulmira; Schepetkin, Igor A; Utegenova, Gulzhakhan A et al. (2017) Chemical composition and phagocyte immunomodulatory activity of Ferula iliensis essential oils. J Leukoc Biol 101:1361-1371
Halonen, Sandra K (2017) Use of Human Neurons Derived via Cellular Reprogramming Methods to Study Host-Parasite Interactions of Toxoplasma gondii in Neurons. Cells 6:
Roe, Mandi M; Swain, Steve; Sebrell, T Andrew et al. (2017) Differential regulation of CD103 (?E integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands. J Leukoc Biol 101:1169-1180
Brutscher, Laura M; Daughenbaugh, Katie F; Flenniken, Michelle L (2017) Virus and dsRNA-triggered transcriptional responses reveal key components of honey bee antiviral defense. Sci Rep 7:6448

Showing the most recent 10 out of 90 publications